Prognostic Utility of Cardiac MRI Myocardial Strain Parameters in Patients With Ischemic and Nonischemic Dilated

Hok Shing Tang1, Chi Ting Kwan1, Jianlong He2

  • 1Department of Diagnostic Radiology, The University of Hong Kong, Rm 406, Block K, Queen Mary Hospital, Hong Kong SAR.

Insights

Left ventricular global longitudinal strain (LV GLS) from cardiac MRI feature tracking predicts adverse outcomes in dilated cardiomyopathy (DCM) patients. This finding supports using LV GLS for improved patient management and risk stratification in DCM.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Conflicting results exist on the prognostic value of myocardial strain parameters from feature tracking (FT) on cardiac MRI in dilated cardiomyopathy (DCM).
  • Previous studies were small and single-center, limiting generalizability.

Purpose of the Study:

  • To assess the prognostic utility of FT parameters on cardiac MRI in patients with ischemic and nonischemic DCM.
  • To identify the optimal strain parameter for predicting adverse outcomes in DCM patients.

Main Methods:

  • Retrospective analysis of 471 DCM patients (ischemic n=233, nonischemic n=238) with LV ejection fraction <50% from four centers (2011-2019).
  • Cardiac MRI with manual contouring and software-based FT to calculate six myocardial strain parameters (radial, circumferential, longitudinal) for LV and RV.
  • Evaluation of late gadolinium enhancement (LGE) and composite outcome (all-cause mortality/heart failure hospitalization).

Main Results:

  • All six FT strain parameters independently predicted the composite outcome (p < .05).
  • In multivariable analysis, only LV global longitudinal strain (LV GLS) remained a significant independent predictor (HR=1.13, p=.006).
  • LV ejection fraction and LGE were not independent predictors in multivariable models. A LV GLS threshold of -6.8% predicted the composite outcome at 4.0 years with 62.6% sensitivity and specificity.

Conclusions:

  • LV GLS derived from FT on cardiac MRI is a significant independent predictor of adverse outcomes in DCM patients.
  • This study supports the clinical implementation of FT for cardiac MRI in DCM patient assessment.
  • LV GLS offers valuable prognostic information beyond traditional measures like LVEF and LGE.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
118
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
20
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
46